Joseph Anderson, Ph.D., holds a B.S. in Chemical Engineering from Arizona State University and both an M.S. and Ph.D. in Chemical Engineering from the University of Washington. Dr. Anderson is an Affiliate Assistant Professor of Bioengineering at the University of Washington and the owner of Anderson Bioscience, a biotechnology consulting company. He has extensive training in bioengineering and physiology. His nearly 30 years of research addressing the exchange of chemicals in the lungs has resulted in more than 50 peer-reviewed publications and 3 book chapters. He has helped develop devices to treat severe pulmonary emphysema, to measure exhaled breath acetone, and to detect COVID infection using breath measurements.
Dr. Anderson’s area of expertise focuses on the mechanisms by which the lung exchanges material and energy between the blood, tissue, and breath. He is an expert in the theory and practice of measuring concentrations of various products in the breath and evaluating measurement uncertainty.
Dr. Anderson’s legal consulting services typically focus on the new paradigm of lung alcohol exchange and biologic factors affecting the measurement of alcohol in the breath and above the skin. He has expertise in the science and practice of alcohol breath testing, transdermal alcohol testing, and mathematical modeling of physiological systems. For additional information, including publications, visit www.andersonbioscience.com or contact him directly at firstname.lastname@example.org.